
Brian Ngo
Examiner (ID: 19153, Phone: (571)270-7011 , Office: P/2851 )
| Most Active Art Unit | 2851 |
| Art Unit(s) | 2825, 2851 |
| Total Applications | 1288 |
| Issued Applications | 1125 |
| Pending Applications | 69 |
| Abandoned Applications | 122 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17454104
[patent_doc_number] => 11268959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Bovine herpesvirus detection and treatment
[patent_app_type] => utility
[patent_app_number] => 16/896985
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 18340
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896985 | Bovine herpesvirus detection and treatment | Jun 8, 2020 | Issued |
Array
(
[id] => 17256608
[patent_doc_number] => 20210369593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Herb and Root Infused Carrier Oil
[patent_app_type] => utility
[patent_app_number] => 16/888752
[patent_app_country] => US
[patent_app_date] => 2020-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888752 | Herb and Root Infused Carrier Oil | May 30, 2020 | Abandoned |
Array
(
[id] => 16391029
[patent_doc_number] => 20200331970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NON-NATURALLY OCCURING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 16/886387
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886387 | Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using | May 27, 2020 | Issued |
Array
(
[id] => 18574300
[patent_doc_number] => 11730806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Methods of manufacturing an immunogenic composition comprising a recombinant protein
[patent_app_type] => utility
[patent_app_number] => 16/879471
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 38281
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879471 | Methods of manufacturing an immunogenic composition comprising a recombinant protein | May 19, 2020 | Issued |
Array
(
[id] => 17843786
[patent_doc_number] => 11433129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Compositions and methods of manufacturing trivalent filovirus vaccines
[patent_app_type] => utility
[patent_app_number] => 16/879668
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 8198
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879668 | Compositions and methods of manufacturing trivalent filovirus vaccines | May 19, 2020 | Issued |
Array
(
[id] => 18216450
[patent_doc_number] => 11591372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/877319
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 119
[patent_no_of_words] => 68619
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877319 | Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof | May 17, 2020 | Issued |
Array
(
[id] => 17733355
[patent_doc_number] => 20220218814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => A VACCINE COMPRISING A NANOPARTICLE ENCAPSULATING EPITOPES AND ADJUVANT FOR NEUTRALIZING VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/609822
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609822 | A VACCINE COMPRISING A NANOPARTICLE ENCAPSULATING EPITOPES AND ADJUVANT FOR NEUTRALIZING VIRUS INFECTION | May 7, 2020 | Pending |
Array
(
[id] => 17602915
[patent_doc_number] => 11331384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Computational algorithm for universal vaccine selection
[patent_app_type] => utility
[patent_app_number] => 16/869901
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 13764
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869901 | Computational algorithm for universal vaccine selection | May 7, 2020 | Issued |
Array
(
[id] => 17177380
[patent_doc_number] => 11154609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => PCV/mycoplasma hyopneumoniae vaccine
[patent_app_type] => utility
[patent_app_number] => 16/860308
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 20270
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860308
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860308 | PCV/mycoplasma hyopneumoniae vaccine | Apr 27, 2020 | Issued |
Array
(
[id] => 17148420
[patent_doc_number] => 11141472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Mycoplasma hyopneumoniae vaccine
[patent_app_type] => utility
[patent_app_number] => 16/859093
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 17770
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859093 | Mycoplasma hyopneumoniae vaccine | Apr 26, 2020 | Issued |
Array
(
[id] => 17168869
[patent_doc_number] => 20210322539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Cure to new viruses and other diseases that do not have current cure
[patent_app_type] => utility
[patent_app_number] => 16/873472
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16873472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/873472 | Cure to new viruses and other diseases that do not have current cure | Apr 16, 2020 | Abandoned |
Array
(
[id] => 18503629
[patent_doc_number] => 11701419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/841485
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 100
[patent_no_of_words] => 96738
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841485 | Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof | Apr 5, 2020 | Issued |
Array
(
[id] => 16341710
[patent_doc_number] => 20200306360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => IMMUNOGENIC COMPOSITIONS AND VACCINES COMPRISING AFRICAN SWINE FEVER VIRUS PEPTIDES AND PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/830412
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16830412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/830412 | Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof | Mar 25, 2020 | Issued |
Array
(
[id] => 17648541
[patent_doc_number] => 11351244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
[patent_app_type] => utility
[patent_app_number] => 16/822830
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21545
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 315
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822830
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822830 | Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning | Mar 17, 2020 | Issued |
Array
(
[id] => 17648540
[patent_doc_number] => 11351243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/809038
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19387
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809038 | North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof | Mar 3, 2020 | Issued |
Array
(
[id] => 17297926
[patent_doc_number] => 20210393765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ROTAVIRUS VP7 FUSION PROTEINS AND ROTAVIRUS-LIKE PARTICLES COMPRISING THEM
[patent_app_type] => utility
[patent_app_number] => 17/431987
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431987 | ROTAVIRUS VP7 FUSION PROTEINS AND ROTAVIRUS-LIKE PARTICLES COMPRISING THEM | Feb 18, 2020 | Abandoned |
Array
(
[id] => 15895367
[patent_doc_number] => 20200147202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE
[patent_app_type] => utility
[patent_app_number] => 16/750437
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750437 | LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE | Jan 22, 2020 | Abandoned |
Array
(
[id] => 16204904
[patent_doc_number] => 20200237894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PCV2 ORF2 CARRIER PLATFORM
[patent_app_type] => utility
[patent_app_number] => 16/749241
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/749241 | PCV2 ORF2 CARRIER PLATFORM | Jan 21, 2020 | Abandoned |
Array
(
[id] => 20241210
[patent_doc_number] => 12421519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Plant colonization assays using natural microbial barcodes
[patent_app_type] => utility
[patent_app_number] => 17/421278
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 91061
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421278 | Plant colonization assays using natural microbial barcodes | Jan 6, 2020 | Issued |
Array
(
[id] => 17482714
[patent_doc_number] => 20220090218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/420442
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -112
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420442 | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS | Jan 2, 2020 | Abandoned |